Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.68 +0.09 (+2.51%)
As of: Sep 30, 2026 · 3:09 PM EDT

Bolt Biotherapeutics (BOLT) Operating Margin (2020 - 2026)

Updated

Bolt Biotherapeutics' Operating Margin came in at -167480.00% for Q2 2026, down 166969.47 percentage points from -510.53% a year earlier and down 138245.38 percentage points from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Operating Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Bolt Biotherapeutics reported Operating Margin of -654.53%, up 657.78 percentage points year-over-year; for FY2025, it was -469.30%, up 480.60 percentage points from FY2024.

  • Operating Margin has increased in each of the last five years, with a five-year change of +20821.60 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was -949.91% in FY2024 (+17.54 pp), -967.45% in FY2023 (+609.11 pp), -1576.56% in FY2022 (+5787.57 pp) and -7364.13% in FY2021 (+13926.78 pp).
  • The Q2 2026 figure represents the lowest quarterly Operating Margin in data going back to Q1 2020.
  • Year-over-year, Operating Margin increased in two of the last six quarters, with an average year-over-year change of -32375.68 percentage points.
  • The fastest year-over-year change in Operating Margin over five years came in Q4 2022 (a gain of 3838.58 percentage points), and the weakest in Q2 2026 (a drop of 166969.47 percentage points).
  • Business Quant data shows BOLT's Operating Margin at -29234.62% (Q1 2026), -283.40% (Q4 2025) and -355.14% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Bolt Biotherapeutics 7.03 Mn 7.03 Mn - -167,480.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -167,480.00%
Mar 31, 2026 -29,234.62%
Dec 31, 2025 -283.40%
Sep 30, 2025 -355.14%
Jun 30, 2025 -510.53%
Mar 31, 2025 -991.41%
Sep 30, 2024 -1,441.10%
Jun 30, 2024 -1,772.31%
Mar 31, 2024 -324.08%
Dec 31, 2023 -946.19%
Sep 30, 2023 -719.26%
Jun 30, 2023 -1,383.95%
Mar 31, 2023 -1,008.49%
Dec 31, 2022 -1,491.14%
Sep 30, 2022 -1,058.05%
Jun 30, 2022 -1,655.35%
Mar 31, 2022 -2,936.78%
Dec 31, 2021 -5,329.72%
Sep 30, 2021 -3,128.46%
Jun 30, 2020 -16,582.09%
API Access

Bolt Biotherapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=BOLT&period=max&api_key=YOUR_API_KEY